###### Strengths and limitations of this study

-   We are in the unusual situation where the assessment of the occurrence of gonorrhoea in Denmark can be based on two continuous nationwide surveillance systems: a mandatory clinical notification system (since 1867) and a voluntary laboratory surveillance system (since 1957). Before the mid-1960s, the majority of notified cases were among men and the majority of laboratory-confirmed cases among women. Since then, culture has also been widely used for the diagnosis of gonorrhoea in men. During the past 40--50 years, both surveillance systems showed marked simultaneous changes in gonorrhoea rates.

-   Between 1974 and 1988, the strength of the data was at a maximum due to the following facts: a case definition was laid down in the Venereal Disease Act 1973, the prevalence of disease was high, the testing activity was high and diagnostic facilities and treatment were available for all medical settings free of charge.

-   The study limitations are due to (1) the lack of information of testing practice for patients without laboratory-confirmed gonorrhoea, that is, the proportion of lost cases is unknown, (2) the fact that both systems are anonymous, that is, we can only estimate the degree of under-reporting or underdiagnosing of cases and (3) possible changes in sexual behaviour cannot be inferred from our data.

Introduction {#s1}
============

In Denmark, information on the epidemiology of gonorrhoea is based on a clinical notification system (since 1867) and a countrywide laboratory surveillance system (since 1957). The public health strategies for the prevention of sexually transmitted diseases (STDs) comprise legislation, health educational programmes and regulations governing control of infectious diseases in general. Legislation specifically dealing with STDs goes back to 1773, including the patients' right to receive free treatment, and was laid down in the 'Act on Measures to Combat the Spread of Venereal Infections' in 1874. In 1877, uniform notification forms for selected communicable diseases including syphilis, gonorrhoea and ulcus venereum (ulcus molle) were introduced. In 1906, a total revision resulted in 'The Act Regarding the Combating of Public Immorality and Venereal Infection'.[@R1]This Act prohibited prostitution, abolished all control systems regarding prostitutes and enabled penal measures to be undertaken against those patients who did not fulfil their duty to comply with examination, treatment and to report the identity of their sexual contacts. The most important step to prevent further spread of the diseases was the continued provision of free treatment at public STD clinics. The next major amendment was in 1947, which, owing to the recent epidemic during World War II (WW2), implied an intensification of rules for contact tracing and duty to receive treatment. The revised law of 1973 stressed an increased personal responsibility for prevention and control of STDs. This trend continued and resulted in the abolition of legislation specifically concerning STDs in 1988. After the abolition of the Venereal Disease Act, the National Board of Health (NBH) still has obligations to supply official guidelines for prevention, diagnosis and treatment of STDs.[@R2] However, the annulment implied that treatment was no longer free of charge except at the few public STD clinics maintained after the decentralisation of public expenses in 1980. The change in legislation released local authorities from the obligation to organise facilities for medical care and contact tracing.

The main objective of this paper is to discuss the importance of sampling from multiple sites and of the availability of appropriate laboratory diagnostic tests for case finding.

Methods {#s2}
=======

Clinical notification system {#s2a}
----------------------------

The system is obligatory and comprises the following STDs (year of first annual report): gonorrhoea (1877), early syphilis (1877) and AIDS (1983); ulcus molle (1877) and lymphogranuloma venereum (1938) were omitted from the notification system from 1994 and onwards.[@R1] Initially, the diagnosis of gonorrhoea was based on symptoms, signs and patient history; after 1884, the diagnosis might be supported by microscopy of Gram-stained smears[@R3] of urogenital secretions; in 1940, facilities for culture of *Neisseria gonorrhoeae* became available at Statens Serum Institut (SSI). A case definition was for the first time laid down in the Venereal Disease Act in 1973: *N. gonorrhoeae* should be demonstrated by microscopy or culture. This implied that standardised laboratory diagnostic services should be available free of charge at SSI for all STD clinics, medical officers (MOs) and authorised general practitioners (GPs).

The obligatory records ('weekly lists') were numerical and anonymous showing distribution according to region, season, age group (15--64 years not subdivided) and gender. The NBH was responsible for annual surveys based on these data. From 1980, the Department of Epidemiology at SSI was responsible for the handling of all data. The most recent revision in 1994 required that notifications included information about diagnostic procedures used, age and gender of individual patients, assumed country of exposure to infection, HIV status, known presence of other STDs and sexual orientation, but no case definition was included.

Laboratory surveillance system {#s2b}
------------------------------

After periods with sentinel assessment of the prevalence of culture-confirmed gonorrhoea cases, a permanent laboratory surveillance system was established at the Neisseria Department, SSI, in 1957.[@R4] After the mid-1960s, laboratory services were gradually decentralised (see below), but the reporting system was maintained through a close, voluntary collaboration between SSI and the local departments of clinical microbiology (DCMs). Culture-confirmed diagnosis of gonorrhoea was provided solely by public laboratories. The reports comprised information about patient's age and gender, infected anatomical sites and medical setting attended. Specific registration of cases of pharyngeal gonorrhoea was included in 1973 and that of rectal gonorrhoea in men in 1981. Since 1994 when mandatory, individual, anonymous laboratory reporting of confirmed cases was included in the law on measures against selected infectious diseases, a central registration of culture-confirmed cases based on isolates received at SSI was maintained. Information about patients who tested negative was not included.

Laboratory diagnosis {#s2c}
--------------------

Microscopy of genital secretions after Gram staining was performed at the STD clinics on the day of attendance. The laboratory procedures for culture of gonococci at SSI developed since 1940[@R5] were based on the comprehensive studies performed earlier by Reymann.[@R8] [Table 1](#BMJOPEN2015008013TB1){ref-type="table"} shows changes in antimicrobial supplements used in media for primary isolation of gonococci. Local DCMs used the same media produced at SSI. Since 2007, nucleic acid amplification tests (NAATs) have been used as a diagnostic supplement. At major STD clinics in Copenhagen, sampling from the rectum became a routine procedure in both genders around 1950[@R9]; the importance of bacteriological diagnosis of pharyngeal infection was not addressed before 1972.[@R10] Subsequently, all STD clinics routinely included taking of pharyngeal specimens from all patients.

###### 

Laboratory diagnosis of gonorrhoea in Denmark during 1957--1996 at the Neisseria Department, Statens Serum Institut: Selected examples of annual surveys of culture-confirmed cases and testing activity

  Period           Antimicrobials added to media for primary isolation of *Neisseria gonorrhoeae* \*   Year   Number of culture-confirmed cases   Testing activity                                                                      
  ---------------- ----------------------------------------------------------------------------------- ------ ----------------------------------- ------------------ -------- --------- --------- --------- ------ ------ ------ ------ -----
  1957--1959       None                                                                                1957   1684                                2299               3983     15 435    60 983    76 418    12.9   8.3    9.2    NA ‡   NA
                                                                                                       1959   2193                                2934               5127     18 352    70 361    88 713    15.4   8.5    9.9    NA     NA
  1960--1964       Polymyxin B sulfate, nystatin or both                                               1960   2835                                3581               6416     20 972    81 491    102 463   16.8   9.5    11.0   NA     NA
                   1964                                                                                2936   2934                                5870               23 491   86 482    109 976   NA        NA     8.8    NA     NA     
  1965--1973       Ristocetin added to the above 1965--1968, and then replaced with vancomycin         1965   3112                                3027               6139     25 465    91 660    117 125   NA     NA     8.8    NA     NA
                   1968                                                                                5918   5675                                11 593             45 867   115 942   161 809   13.2      9.1    9.7    1.2    2.1    
                   1972                                                                                9054   8349                                17 403             79 362   224 256   314 311   11.5      6.4    7.2    1.2    2.1    
                   1973                                                                                8731   7444                                16 175             81 974   218 037   311 946   10.7      5.8    6.7    1.2    2.2    
  1974--1979 ^§^   1\) Polymyxin B sulfate, nystatin, vancomycin 2) trimethoprim lactate               1974   7934                                6726               14 660   82 519    236 845   323 211   10.9   4.7    5.8    1.5    2.2
                   1979                                                                                5790   4884                                10 674             79 502   240 773   320 275   7.5       3.2    4.2    1.6    2.1    
                                                                                                                                                                                                                                        
  1980--1996       Amphotericin B, lincomycin, polymyxin B sulfate, trimethoprim lactate               1980   6043                                4798               10 841   78 289    225 717   304 006   8.0    3.4    4.6    1.6    2.1
                   1983                                                                                5545   4418                                9963               85 217   187 644   272 861   6.8       3.8    4.7    1.8    2.0    
                   1988                                                                                1362   1136                                2498               38 174   87 944    126 198   3.6       1.9    2.4    1.7    1.9    
                   1995                                                                                50     12                                  62                 3778     9137      12 915    1.3       0.14   0.48   1.4    1.5    
                   1996                                                                                25     13                                  38                 2481     7143      9 624     1.0       0.21   0.39   1.1    1.3    

\*Concentrations of antimicrobials used in selective media: polymyxin B sulfate 25 U/mL; nystatin 25 U/mL; ristocetin 10 µg/mL; vancomycin 2 µg/mL; amphotericin B 2 µg/mL; lincomycin 1 µg/mL; trimethoprim lactate 3 µg/mL.

†Possible sampling sites included urethra (cervix), rectum and pharynx.

^‡^NA=data not available.

§All specimens inoculated onto both media.

Results {#s3}
=======

Clinical notification system {#s3a}
----------------------------

[Figure 1](#BMJOPEN2015008013F1){ref-type="fig"} shows the annual incidence of gonorrhoea based on the number of cases notified to the NBH since the year 1900; the years of major amendments on legislation (1906, 1947, 1973, 1988) and changes of the clinical notification system (1980, 1994) are indicated. The changes in gonorrhoea rates observed were not closely related to these legislative approaches. For comparison, changes in the incidences of early syphilis and AIDS are included. The gonorrhoea and syphilis curves are fairly congruent apart from the 1970s when only gonorrhoea rates were increased. The occurrence of AIDS reached peak figures in the 1990s.

![Annual incidence (cases per 100 000 population) of gonorrhoea and early syphilis during 1901--2010 and of AIDS during 1981--2010 reported to the National Board of Health. Years of major amendments on legislation: 1906 The Act regarding the combating of public immorality and venereal infections; 1947 and 1973 Amendments of The Venereal Disease Act; 1980 and 1994 Revision of the notification system for communicable diseases; 1988 Abolition of The Venereal Disease Act.](bmjopen2015008013f01){#BMJOPEN2015008013F1}

During WW1, a gonorrhoea epidemic peaking in 1919 with an incidence of 474/100 000 occurred; subsequently, the gonorrhoea incidence fell to the lowest ever recorded at that time. Another epidemic occurred during WW2 (1944: 583/100 000). However, after the war, the steady decrease in prevalence continued until the mid-1960s except for a small peak around 1962--1963 due to an outbreak concurrent with an epidemic of syphilis among homosexual men.[@R11] Then a marked increase peaking in 1972 (344/100 000) was seen. Within the following 20 years, the decrease was dramatic except for a slight increase in the beginning of the 1980s, again due to an outbreak among homosexual men ([figure 1](#BMJOPEN2015008013F1){ref-type="fig"})[@R12] (1982:39; 1987:49).

Since the beginning of the 1990s, the gonorrhoea rate has been at a low endemic level (\<10/100 000), attaining a minimum in 1996 (1.5/100 000). Subsequently, minor clusters occurred among men during 1999--2000 and 2004--2006 and another among both genders during 2009[@R12] (2010:36). Data available for the period 1994--2010 showed that the majority of gonorrhoea cases were among men: on the average, 45% (range 27--61%) had acquired the infection by homosexual contact and 29% (range 14--39%) had acquired the infection abroad; during 1994--2007, 8% (range 5--18%) were known to be HIV positive[@R12] (2006:19; 2007:17; 2008:21; 2009:22; 2010:36; 2011:34a).

In 2003, after a period with decreasing notification rates as compared to those of laboratory-confirmed cases, a reminder system based on laboratory reports to SSI was introduced. The reporting form and an explanatory letter concerning the duty to report were sent to the clinician attended by the patient. The result was a marked increase in numbers of notified cases[@R12] (2004:50). Overall, data from the past two decades show a very low number of gonorrhoea cases.

Laboratory surveillance system {#s3b}
------------------------------

Age groups being used in the clinical notification system did not allow calculation of STD-relevant age-specific incidences why [table 2](#BMJOPEN2015008013TB2){ref-type="table"} is based on data from the laboratory surveillance system. The male/female incidence ratios within the highly exposed age groups 15--19, 20--24 and 25--29 years were constant during the period 1957--1990; subsequently, the total ratios were from three to seven times higher than previously recorded; the annual variation was pronounced, especially for the age group 25--29 years. The ratios for the age group 30--34 years (data not shown) were similar to those for the 25--29 years age group. It should be noted that the numeric basis for the ratios changed dramatically over time, for example, in 1972, the incidences per 100 000 for men and women aged 20--24 years were 1821 and 1468, respectively, and in 1996 they were 16 and 6.

###### 

Incidence of culture-confirmed gonorrhoea per 100 000 population and male/female incidence ratios for the age groups 15--19, 20--24, 25--29 years and total

  Year   Population (thousands)   Incidence per 100 000   Male/female incidence ratios                  
  ------ ------------------------ ----------------------- ------------------------------ ------ ------- ------
  1960   4566                     140.5                   0.29                           0.94   1.29    0.80
  1965   4741                     129.5                   0.34                           1.07   1.89    1.05
  1970   4907                     307.1                   0.36                           1.18   1.88    1.11
  1975   5054                     259.5                   0.42                           1.24   1.92    1.25
  1980   5122                     215.5                   0.46                           1.29   1.94    1.29
  1985   5111                     191.7                   0.56                           1.21   1.84    1.27
  1990   5135                     38.8                    0.47                           1.27   1.80    1.36
  1995   5216                     5.5                     0.30                           2.60   3.71    3.34
  2000   5330                     6.3                     2.16                           5.30   5.50    6.77
  2005   5411                     7.9                     2.57                           3.22   10.61   7.40
  2010   5535                     6.7                     1.07                           1.49   2.46    2.85

Selected data from annual surveys, 1957--2010.

Before the mid-1960s, the majority of female cases were identified by culture ([table 1](#BMJOPEN2015008013TB1){ref-type="table"}), whereas the majority of male cases notified were based on microscopy and not registered in the laboratory surveillance system. During 1965--1988, the numbers of notified and culture-confirmed cases were approximately equal; however, the numbers of notified cases in men were consistently higher than those of culture-confirmed cases and vice versa in women. An attempt to estimate the numerical overlap between the two anonymous surveillance systems was made in 1981 on the basis of the gender, time and medical setting attended (data not shown). The analysis indicated an under-reporting at about 40%. Until 1988, most cases (80--90%) were diagnosed at the Neisseria Department. Following the abolition of The Venereal Disease Act in 1988 according to which diagnostic services had been available free of charge at SSI, such services were established at local DCMs. In 1996 and 2010, only 18% and 6% of confirmed cases were identified at SSI. During 2007--2010, the percentage of notified cases based on the culture of *N. gonorrhoeae* decreased from 94 to 75. Simultaneously, the percentage confirmed by NAATs increased from 0.6 to 17[@R12] (2008:21; 2011:34a).

[Table 1](#BMJOPEN2015008013TB1){ref-type="table"} shows selected examples of the annual surveys comprising gonorrhoea cases confirmed by culture of *N. gonorrhoeae* at SSI during 1957--1996. During the period from 1974 to 1988, the Venereal Disease Act of 1973 including the access to free diagnostic service was functional. It was characterised by a high testing activity and a high prevalence of gonorrhoea. Among 2 038 569 patients tested at the Neisseria Department, 141 356 patients (78 213 men and 63 143 women) with a culture-confirmed diagnosis were identified.

Among factors crucial for the recovery rate of gonococci in clinical samples, the medium used for primary isolation and the clinical practice for sampling are important. [Table 1](#BMJOPEN2015008013TB1){ref-type="table"} shows changes in antimicrobial supplements used over time; in particular, those including vancomycin have been recommended.[@R7] [@R13] [@R14] However, a priori, vancomycin was found to inhibit 3--5% of circulating gonococcal strains.[@R7] To avoid selection and spread of the vancomycin-susceptible strains, all specimens received during 1974--1979 were inoculated onto two media, one with and one without antibiotic supplement. Owing to the high number of specimens that had to be handled in the early 1970s, this laborious and expensive procedure needed simplification. Lincomycin at a concentration that did not inhibit any current strains replaced vancomycin in late 1979.[@R14] To ensure that a selection of strains susceptible to lincomycin or other additives did not emerge and spread, duplicate inoculation onto selective as well as non-selective media was done during a 6-week period every second year from 1981 to 1991. No evidence of selection was found. The combined results for a total of 133 710 specimens tested in duplicate were as follows: percentages of gonococcal isolates recovered on non-selective medium as compared to the selective medium in specimens from urethra: 84; cervix: 73; rectum: 28 and pharynx: 11.[@R15] During the past two decades, a pronounced variation in testing activity was evident, especially in men ([figure 2](#BMJOPEN2015008013F2){ref-type="fig"}). Another crucial factor for case finding in general and asymptomatic infections in particular is the clinical practice for sampling, that is, the importance of testing all possibly infected anatomical sites (complete sampling: urethra, (cervix), rectum and pharynx). As a marker for testing activity, the average numbers of specimens received per case identified were used ([table 1](#BMJOPEN2015008013TB1){ref-type="table"}). The highest testing activity was found during the period 1974--1988 with an average of 1.5--1.8 per male and 1.9--2.2 per female case identified. On the average, 36% (range 30--42%) of male and 25% (range 19--30%) of female patients with gonorrhoea were tested for pharyngeal gonorrhoea. During 1979, the composition of the selective medium and the laboratory procedure (inoculation onto one vs two media per specimen) were changed ([table 1](#BMJOPEN2015008013TB1){ref-type="table"}). It is noteworthy that the average of the recovery percentages then increased from 6% and 12% (1974--1978) to 12% and 19% (1980--1988) in men and women, respectively. Among patients with pharyngeal gonorrhoea, 40% of men and 30% of women had no concomitant urogenital gonorrhoea. During the period 1980--1988, 34% (range 29--40%) of men with gonorrhoea were tested for rectal infection; 9% (range 3--13%) were positive and the rectum was the only infected site in 67% (range 52--77%).

![Prevalence of culture-confirmed pharyngeal and rectal gonorrhoea in men during 1973--2010.](bmjopen2015008013f02){#BMJOPEN2015008013F2}

After the abolition of the Venereal Disease Act in 1988, local authorities closed the majority of STD clinics; hence, this clinical service was attended to by local general practitioners (GPs); simultaneously, a decrease in the average number of sampling sites was recorded.

During 1994--2010, the annual numbers of cases, especially in women, were low. To assess the impact of possible differences in current sampling practice of GPs and STD clinics, we pooled data for patients attending these two settings during the period 2003--2010. Complete sampling was reported for only 9% among 1873 patients with gonorrhoea (1523 men and 350 women) seen by GPs, but for 70% among 990 patients (853 men and 137 women) attending STD clinics. Thus, these findings confirm that differences in sampling tradition still exist. However, among patients with complete sampling ([table 3](#BMJOPEN2015008013TB3){ref-type="table"}), the percentages of patients with urogenital, rectal, rectal only, pharyngeal or pharyngeal only gonorrhoea were similar for patients seen by GPs and for those attending STD clinics.

###### 

Anatomical sites of infection in patients with gonorrhoea with complete sampling for culture of *Neisseria gonorrhoeae*, pooled data from 2003 to 2010

                                       GPs    STD clinics         
  ------------------------------------ ------ ------------- ----- -----
  Number of patients with gonorrhoea   1523   350           853   137
  Site of infection, %                                            
   Urogenital                          89     100           88    91
   Rectal                              15     22            15    22
   Rectal only                         8      0             10    6
   Pharyngeal                          8      7             7     11
   Pharyngeal only                     2      0             2     3

GPs, general practitioners; STD, sexually transmitted diseases.

Discussion {#s4}
==========

The clinical and the laboratory surveillance systems revealed the same changes in the gonorrhoea rate. As in other North-Western European countries, WW1 and WW2 as well as changes in social and economic conditions were associated with a high prevalence of syphilis and gonorrhoea.[@R16] [@R17] No direct association between legislative approaches and changes in reported rates could be demonstrated ([figure 1](#BMJOPEN2015008013F1){ref-type="fig"}). Our data do illustrate the trends; nevertheless, both systems represent minimum figures since up to 40% under-reporting as well as under-diagnosing were noted periodically.

In Denmark, the very high prevalence of gonorrhoea in both genders in the beginning of the 1970s had a complex background. Factors which were used to explain the increase starting in 1965--1966 were not changed when the decrease started in 1973, namely the extended use of oral contraceptives (since 1965), changes in social family patterns with an increasing number of women working outside their homes, and an economy that allowed young people to travel abroad and to live on their own. Why did the observed incidence of gonorrhoea then decrease from 1972 to 1978? Around 1972, the following changes improving case finding were known to occur: the standard laboratory procedure for culture of gonococci was improved, especially increasing the recovery rates for pharyngeal and rectal specimens; simultaneously, asymptomatic pharyngeal gonorrhoea was recognised as a reservoir for which the standard treatment regimens were insufficient.[@R10] It is thus possible that the high testing activity during the 1970s resulted in a reduction of the reservoir of patients with asymptomatic infections which partly may explain the decreasing gonorrhoea rate seen from 1972 onwards. Using NAATs as a diagnostic tool in the high-risk group patients, one recent study showed that isolated anorectal and oropharyngeal infections in patients with gonorrhoea accumulated to 76% of all infections in homosexual men and 59% of all infections in female swingers and prostitutes,[@R18] and another showed that 91% of rectal or pharyngeal infections in homosexual men would remain undetected if only symptomatic cases were tested.[@R19]

The performance characteristics and the heterogeneity of national STD surveillance systems in the European Union and Norway were analysed on the basis of a cross-sectional survey carried out in 2002--2003. The need for standardised case definitions and a minimum data set was underlined.[@R20] In our study, the comparison of the performance of the surveillance systems was based on data from the high prevalence period 1974--1988 when the clinical notification system included a case definition, when testing and treatment were free of charge and when the laboratory service was centralised at a highly specialised unit at SSI (the WHO collaborating centre for reference and research in gonococci). On the basis of data from this period, we concluded that important factors for case finding---including patients with non-genital gonorrhoea---are clinical practice for specimen taking and the performance of diagnostic tests available. However, no information was available regarding complete or incomplete sampling of patients without culture-confirmed gonorrhoea.

Since the late 1970s, the concept of core groups has developed.[@R21] Traditionally, female prostitutes were considered the source of STDs and the core group for legislation and prevention strategies; most recently, the focus has been on homosexual men,[@R22] especially due to their role in HIV transmission.[@R25] The increasing male/female age-specific incidence ratios ([table 2](#BMJOPEN2015008013TB2){ref-type="table"}) were consistent with the finding that in recent years, on the average, 45% of men had acquired the infection by homosexual contact.

Around 1984, the emerging AIDS epidemic motivated an official information campaign focusing on the promotion of safe sex. From this point, a marked decrease in the prevalence of male rectal gonorrhoea, in parallel with the overall decrease in the gonorrhoea rate, was seen. It is a matter of concern that during the same period, when the patients---or rather the homosexual male population---responded adequately to the information given, the medical profession responded in an inadequate way: the percentage of patients from whom a rectal specimen was taken fell markedly ([figure 2](#BMJOPEN2015008013F2){ref-type="fig"}). A similar pattern of changes was observed concerning the taking of pharyngeal specimens.

The result was a decrease in the percentage of patients in whom all possibly infected sites were examined. A comprehensive British study on sexual practice and attitudes recorded an expansion of heterosexual repertoires---particularly in oral and anal sex---over time (1990--2008).[@R26] This finding underlines the importance of complete sampling in all patients on each occasion. Recently, it has been shown in patients at risk of STDs that universal testing is more sensitive in detecting anorectal infection than standard symptom-based and sexual history-based testing.[@R27]

The failure to demonstrate an influence of legal measures on the prevalence of gonorrhoea is in accordance with the following assessment in 1914 of the effect of 'The Act Regarding the Combating of Public Immorality and Venereal Infection' from 1906[@R28]: "I regret to be obliged to state that these statistics, such as they are, and perhaps of limited value, at all events do not support the hopes of the promoters of the new sanitary system. The number of cases of syphilis and venereal disease in Denmark has not been reduced. The State regulation of prostitution has been a sanitary failure. The State regulation of venereal diseases by compulsory measures has been the same. I believe in extensive treatment, and still more in hygienic and preventive measures, which last may be the road of the future. The State has used till now the weapon of prohibition, but I believe the fight against these diseases must be left to the trained medical army, with the least possible assistance from the penal code and the police."

Conclusions {#s5}
===========

If homosexual men are considered the core group which maintains gonorrhoea at an endemic level in the general population, then the previous overall and continued decrease could be explained by the fact that the prevalence within the core group became so low that it continued to decrease outside the core group without any changes in behaviour of that group. The recent increase, especially in men, might be due to the insufficient sampling activity and other shortcomings of diagnostic procedures.[@R29] [@R30] A further decrease in use of culture of *N. gonorrhoeae* is a matter for major concern as to the control of spread of antimicrobial resistance.[@R31]
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